DM-005
- Generic Name
- DM-005
A Study of DM005 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungSolid Carcinoma
- Interventions
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Doma Biopharmaceutical（Suzhou）Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT06515990
- Locations
- 🇦🇺
ICON Cancer Center, South Brisbane, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath